No Data
Hong Kong stocks move | CRO Concept stocks plunged sharply in the morning as the USA plans to tighten investment restriction policies. Institutions say there is a risk of short-term impact on market sentiment.
CRO Concept stocks plummeted in the morning; as of the time of writing, WUXI APPTEC (02359) is down 9%, trading at 63.7 Hong Kong dollars; FRONTAGE (01521) is down 6.99%, trading at 1.33 Hong Kong dollars; PHARMARON (03759) is down 5.83%, trading at 18.1 Hong Kong dollars; TIGERMED (03347) is down 5.7%, trading at 36.4 Hong Kong dollars.
Trending Industry Today: WUXI BIO Leads Losses In CRO Stocks
Trending Industry Today: TIGERMED Leads Gains In CRO Stocks
Hong Kong stocks fluctuated | CRO Concept stocks continued to surge in the morning, WUXI BIO (02269) and TIGERMED (03347) both rose over 9%.
In the early session, CRO Concept stocks continued to rise. As of the time of writing, WUXI BIO (02269) is up 9.59%, priced at 22.85 HKD; TIGERMED (03347) is up 9.09%, priced at 31.2 HKD; GENSCRIPT BIO (01548) is up 7.22%, priced at 11.88 HKD.
The "DeepSeek Moment" of medicine, has China’s Innovative Drugs also reached it?
Over the past four years, China's share of Global large-scale pharmaceutical Trade has surged from 5% to 30%. From research and development innovation to international mergers and acquisitions, Chinese Innovative Drugs companies are reshaping the Global pharmaceutical innovation landscape.
Hong Kong stocks movement | CRO Concept stocks rose broadly in the morning as Innovative Drugs continue to expand overseas. The Global interest rate cuts help improve CXO overseas Business.
CRO Concept stocks experienced a general rise in the morning session. As of the time of writing, FRONTAGE (01521) rose by 5.88%, trading at 1.8 HKD; WUXI APPTEC (02359) rose by 4.97%, trading at 57 HKD; WUXI BIO (02269) rose by 3.64%, trading at 18.2 HKD; PHARMARON (03759) rose by 3.21%, trading at 14.14 HKD.
Despite Hitting HK$1.67, Frontage Holdings Insiders Still Sold Too Soon
